Co-occurrence of amyotrophic lateral sclerosis and Charcot-Marie-Tooth disease type 2A in a patient with a novel mutation in the mitofusin-2 gene

被引:18
作者
Marchesi, Chiara
Ciano, Claudia
Salsano, Ettore
Nanetti, Lorenzo
Milani, Micaela [2 ]
Gellera, Cinzia [2 ]
Taroni, Franco [2 ]
Fabrizi, Gian Maria [3 ]
Uncini, Antonino [4 ,5 ]
Pareyson, Davide [1 ]
机构
[1] IRCCS Fdn, Dept Clin Neurosci, Unit Clin Cent & Peripheral Degenerat Neuropathie, Besta Neurol Inst C, I-20133 Milan, Italy
[2] IRCCS Fdn, Unit Genet Neurodegenerat & Metab Dis, Besta Neurol Inst C, I-20133 Milan, Italy
[3] Univ Verona, Sect Clin Neurol, Dept Neurol & Visual Sci, I-37100 Verona, Italy
[4] Univ G DAnnunzio Fdn, Inst Aging CeSI, Dept Human Motor Sci, Chieti, Italy
[5] Univ G DAnnunzio Fdn, Inst Aging CeSI, Neurodegenerat Dis Unit, Chieti, Italy
关键词
Charcot-Marie-Tooth neuropathy; Amyotrophic Lateral Sclerosis; CMT2A; Mitofusin-2; Motor neuron disease; MFN2; MUTATIONS; NEUROPATHY;
D O I
10.1016/j.nmd.2010.09.009
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Mitofusin-2 gene (MFN2) mutations cause Charcot-Marie-Tooth type 2A (CMT2A), sometimes complicated by additional features such as optic atrophy, hearing loss, upper motor neuron signs and cerebral white-matter abnormalities. Here we report, for the first time, the occurrence of motor neuron disease, consistent with amyotrophic lateral sclerosis (ALS), in a 62-year-old woman affected by early-onset slowly progressive CMT2A, due to a novel MFN2 mutation. After age 60, rate of disease progression changed and she rapidly developed generalised muscle wasting, weakness, and fasciculations, together with dysarthria and dysphagia. Clinical features, EMG findings, and fast progression were consistent with ALS superimposed on CMT. (C) 2010 Elsevier By. All rights reserved.
引用
收藏
页码:129 / 131
页数:3
相关论文
共 50 条
  • [31] Mitochondrial GTPase mitofusin 2 mutations in Korean patients with Charcot-Marie-Tooth neuropathy type 2
    Cho, H-J
    Sung, D. H.
    Kim, B. J.
    Ki, C-S
    CLINICAL GENETICS, 2007, 71 (03) : 267 - 272
  • [32] Clinical Phenotype in an Early-Onset French Pediatric Population: Charcot-Marie-Tooth's Disease Type 2A
    Majorel-Beraud, C.
    Baudou, E.
    Walther-Louvier, U.
    Espil-Taris, C.
    Beze-Beyrie, P.
    Cintas, P.
    Rivier, F.
    Cances, C.
    NEUROPEDIATRICS, 2021, 52 (05) : 351 - 357
  • [33] Novel mutation in the periaxin gene causal to Charcot-Marie-Tooth disease type 4F
    Chen, Yu-hui
    Zhang, Hua
    Meng, Ling-bing
    Tang, Xiao-yan
    Gong, Tao
    Yin, Jian
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2020, 48 (02)
  • [34] A novel mutation in the FGD4 gene causing Charcot-Marie-Tooth disease
    Zis, Panagiotis
    Reilly, Mary M.
    Rao, Dasappaiah G.
    Tomaselli, Pedro
    Rossor, Alex M.
    Hadjivassiliou, Marios
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2017, 22 (03) : 224 - 225
  • [35] Adenine nucleotide translocase is involved in a mitochondrial coupling defect in MFN2-related Charcot-Marie-Tooth type 2A disease
    Guillet, Virginie
    Gueguen, Naig
    Verny, Christophe
    Ferre, Marc
    Homedan, Chadi
    Loiseau, Dominique
    Procaccio, Vincent
    Amati-Bonneau, Patrizia
    Bonneau, Dominique
    Reynier, Pascal
    Chevrollier, Arnaud
    NEUROGENETICS, 2010, 11 (01) : 127 - 133
  • [37] Vincristine exacerbates asymptomatic Charcot-Marie-Tooth disease with a novel EGR2 mutation
    Nakamura, Tomonori
    Hashiguchi, Akihiro
    Suzuki, Shinsuke
    Uozumi, Kimiharu
    Tokunaga, Shoko
    Takashima, Hiroshi
    NEUROGENETICS, 2012, 13 (01) : 77 - 82
  • [38] Involvement of Charcot-Marie-Tooth disease gene mitofusin 2 expression in paclitaxel-induced mechanical allodynia in rats
    Yamashita, Yuta
    Irie, Keiichi
    Kochi, Akane
    Kimura, Nami
    Hayashi, Toshinobu
    Matsuo, Koichi
    Myose, Takayuki
    Sano, Kazunori
    Nakano, Takafumi
    Takase, Yumi
    Nakamura, Yoshihiko
    Satho, Tomomitsu
    Mishima, Kenji
    Mishima, Kenichi
    NEUROSCIENCE LETTERS, 2017, 653 : 337 - 340
  • [39] Combined RNA interference and gene replacement therapy targeting MFN2 as proof of principle for the treatment of Charcot-Marie-Tooth type 2A
    Rizzo, Federica
    Bono, Silvia
    Ruepp, Marc David
    Salani, Sabrina
    Ottoboni, Linda
    Abati, Elena
    Melzi, Valentina
    Cordiglieri, Chiara
    Pagliarani, Serena
    De Gioia, Roberta
    Anastasia, Alessia
    Taiana, Michela
    Garbellini, Manuela
    Lodato, Simona
    Kunderfranco, Paolo
    Cazzato, Daniele
    Cartelli, Daniele
    Lonati, Caterina
    Bresolin, Nereo
    Comi, Giacomo
    Nizzardo, Monica
    Corti, Stefania
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2023, 80 (12)
  • [40] Altered interplay between endoplasmic reticulum and mitochondria in Charcot-Marie-Tooth type 2A neuropathy
    Bernard-Marissal, Nathalie
    van Hameren, Gerben
    Juneja, Manisha
    Pellegrino, Christophe
    Louhivuori, Lauri
    Bartesaghi, Luca
    Rochat, Cylia
    El Mansour, Omar
    Medard, Jean-Jacques
    Croisier, Marie
    Maclachlan, Catherine
    Poirot, Olivier
    Uhlen, Per
    Timmerman, Vincent
    Tricaud, Nicolas
    Schneider, Bernard L.
    Chrast, Roman
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (06) : 2328 - 2337